StATS: Upcoming talks about control charts (created 2006-05-25).

I am working on some ideas for a grant to use control charts to track adverse events in clinical trials. I also envision the possibility of using control charts as a warning of a sudden influx of events that may be an early indicator of a bioterrorism event. I have not fleshed out these ideas very completely yet, but hope to do so soon in the weblog.

While reviewing the upcoming talks at the Joint Statistics Meeting in Seattle, August 2006, I noticed several interesting talks that appear to be related to some of the things I might be working on.

Session 317, Tuesday 2:00pm

• Abstract - #304973. The Use of Control Charts in Health Care Monitoring and Public Health Surveillance. William H. Woodall
• Abstract - #304984. Cumulative Sum Methods for Spatial Surveillance. Peter A. Rogerson
• Abstract - #305169. Performance of Residual-Based Control Charts Using Generalized Exponential Smoothing of Syndromic Data for Routine Health Surveillance. Howard S. Burkom and Galit Shmueli and Sean Murphy
• Abstract - #305299. A Neural Network Approach to Control Charts with Applications to Health Surveillance. Benjamin M. Adams and Kidakan Saithanu and J. Michael Hardin

Other sessions

• Abstract - #306832. Detection of Outbreaks in Syndromic Surveillance Data Using Monotonic Regression. Jared Burdin and James Dunyak and Mojdeh Mohtashemi and Martin Kulldorff (Monday, 10:30am)
• Abstract - #307392. A Wavelet-Based Method for the Prospective Monitoring of Disease Incidence Counts in Space and Time. J. Brooke Marshall and Dan Spitzner and William H. Woodall (Monday 10:30am)

Ironically, the two Monday talks are in different sessions.

This page was written by Steve Simon while working at Children's Mercy Hospital. Although I do not hold the copyright for this material, I am reproducing it here as a service, as it is no longer available on the Children's Mercy Hospital website. Need more information? I have a page with general help resources. You can also browse for pages similar to this one at Category: Adverse events in clinical trials.